Abstract: A method for attaching lining elements to a structure exposed to wear using an interface engagement fastening arrangement is disclosed. The method involves the steps of attaching strips or sheets provided with a first part of the interface engagement fastening arrangement to a mounting surface of the structure; providing lining elements to the exposed first part of the interface engagement fastening arrangement so that these parts are inter-engaged. By this engagement of the first and second parts of the interface engagement fastening arrangement, the aimed-at lining element mounting is obtained.

Abstract: A lining element includes at least three layers and is configured to be mounted to a structure exposed to wear. The lining element has a wear-impeding polymer layer, an energy-absorbing polymer layer and a reinforcing polymer layer. The reinforcing layer is located adjacent the structure exposed to wear, whereas the energy-absorbing layer is located between the reinforcing layer and the wear-impeding layer. The wear-impeding layer is located on top of the energy-absorbing layer.

Abstract: A lining element includes at least three layers and is configured to be mounted to a structure exposed to wear. The lining element has a wear-impeding polymer layer, an energy-absorbing polymer layer and a reinforcing polymer layer. The reinforcing layer is located adjacent the structure exposed to wear, whereas the energy-absorbing layer is located between the reinforcing layer and the wear-impeding layer. The wear-impeding layer is located on top of the energy-absorbing layer.

Abstract: A cargo loading and monitoring system for an aircraft having a plurality of separate cargo compartments includes a processor in communication with a plurality of power drive units located within a first cargo compartment. A cargo monitoring display unit is located in a second cargo compartment that is separate from the first cargo compartment, and is in communication with the processor. The cargo monitoring display unit is configured to selectively display information received from the power drive units.

Abstract: An integrated cargo loading and video monitoring system for an aircraft having at least one cargo compartment is disclosed. The system includes a cargo loading processor and a plurality of power drive units within the cargo compartment, each power drive unit being coupled to the cargo loading processor. The system also includes a video processor, and at least one video camera within the cargo compartment, the camera being coupled to the video processor. A central processor in communication with the cargo loading processor and the video processor is operable to receive information from both the cargo loading processor and from the video processor.

Abstract: This invention provides a method for inhibiting the release of interleukin-1? in a mammal. This invention also provides a method for preventing or treating pulmonary diseases, ophthalmic diseases, and autoimmune diseases that are associated with inflammation or inflammatory conditions. The invention also provides a method for preventing or treating neurodegenerative diseases, or pain in a mammal. The method comprises administering to a mammal in need thereof a therapeutically effective amount of a mononucleoside compound, which is an antagonist of P2X7 receptor.

Abstract: A cargo loading and monitoring system for an aircraft having a plurality of separate cargo compartments includes a processor in communication with a plurality of power drive units located within a first cargo compartment. A cargo monitoring display unit is located in a second cargo compartment that is separate from the first cargo compartment, and is in communication with the processor. The cargo monitoring display unit is configured to selectively display information received from the power drive units.

Abstract: This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae III, IIIa, and IIIb, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae IIIa and IIIb, which are potent and have a good oral bioavailability.

Abstract: This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae III, IIIa, and IIIb, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae IIIa and IIIb, which are potent and have a good oral bioavailability.